FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), announces that it has signed a non-binding agreement to acquire Vector Biosource Inc. (“Vector”). Vector is an information and biospecimen ...

FOXO Technologies (FOXO) has signed a non-binding agreement to acquire Vector Biosource. Vector is an information and biospecimen sourcing ...

Researchers at the University of Tsukuba have developed a vector that integrates the Cre enzyme gene with the specific DNA ...

Key Takeaways Tick bites can cause a rare red meat allergy called alpha-gal syndromeResearch shows more types of ticks may be ...

The National Institutes of Health are the world’s largest funder of medical research, distributing $35 billion in in grants ...

Immunotherapy has emerged as one of the major options for cancer treatment in the past decade. With the successful application of immune checkpoint inhibitors and the introduction of immune regulatory ...

Transgenic animals continue to play an essential role in many aspects of zebrafish research, including the development of disease models. The most widely used system for zebrafish transgenesis is the ...

Oppenheimer began coverage on shares of Lam Research (NASDAQ:LRCX – Free Report) in a research report released on Thursday morning. The brokerage issued an outperform rating and a $95.00 target price ...

An ECB study reveals that negative interest rates, combined with Austrian legal constraints, compressed bank profit margins ...

At first glance, this seems like a win for transparency. If an AI explains itself, we can understand its motives, catch ...

Learn more about the next evolution of Security Copilot with AI agents designed to autonomously assist with phishing, data ...

Cyberattacks are no longer an abstract threat – they dominate risk planning for companies worldwide. The latest Link11 ...